Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial. J of Skin [Internet]. 2025 Jan. 13 [cited 2025 May 30];9(1):s512. Available from: https://skin.dermsquared.com/skin/article/view/3151